EVERESTO

Everest Organics Ltd.

BSE: 524790

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

298.05-10.9 (-3.53%)

7 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

13.4 / 100

Value Score

26.2 / 100

Price Momentum Score

19.8 / 100

QVM Score

5.7 / 100

Key Metrics

Market Cap

289.44

P/E (TTM)

52.18

P/B

3.83

P/S (TTM)

1.48

EV/EBITDA

17.11

CAPE (5Y)

363.15

ROE (TTM)

7.63

ROCE (TTM)

10.96

ROA (TTM)

2.39

Avg 3Y ROE

1.90

Earnings 3Y CAGR

Sales 3Y CAGR

2.33

Sales 5Y CAGR

1.56

Debt/Equity

0.66

Consensus TP

Strong Buy %

Promoter Holding

59.60

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Everest Organics Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Not enough talking points with positive stance

Negative

Expensive and at a premium to industry median P/E

PE TTM of 52.18 indicates that the stock is expensive on a standalone basis and is at a 70.58% premium to industry median P/E

What is P/E Ratio?

Median: 30.59

Value 52.18

0.33286.35

Weak price momentum

Price Momentum score of 19.8 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term

What is Price Momentum score?

19.8 / 100

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 33.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

33.0 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Everest Organics Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Everest Organics Ltd. Shareholding Pattern

Quarterly breakdown of Everest Organics Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	73.79	73.79	73.79	74.04	74.15	74.15	74.15	74.15	74.15	74.15	74.15	74.15	74.15	74.15	74.15	74.15	74.15	74.15	74.15	74.15	61.09	60.99	59.64	59.61	59.58	59.60
Indian Promoter	71.67	71.67	71.67	71.92	72.04	72.04	72.04	72.04	72.04	72.04	72.04	72.04	72.04	72.04	72.04	72.04	72.04	72.04	72.04	72.04	59.35	59.25	57.90	57.87	57.84	57.86
Foreign Promoter	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	2.11	1.74	1.74	1.74	1.74	1.74	1.74
Institutions	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.02
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.02
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	26.19	26.19	26.19	25.94	25.82	25.82	25.82	25.82	25.82	25.82	25.82	25.82	25.82	25.82	25.82	25.82	25.82	25.82	25.82	25.82	38.89	38.99	40.34	40.37	40.40	40.37
Bodies Corporate	2.57	2.56	2.75	2.77	2.67	2.75	2.78	2.77	2.70	2.74	2.74	2.71	2.80	2.81	2.79	2.81	2.81	2.78	2.74	4.01	12.28	8.91	8.94	8.05	8.59	8.46
Others (incl. Retail) No. of shareholders	23.62 7,035	23.63 7,542	23.44 8,099	23.17 7,849	23.15 8,052	23.07 11,094	23.04 10,705	23.05 11,058	23.12 11,078	23.08 11,167	23.08 11,172	23.11 11,024	23.02 10,761	23.01 10,561	23.03 10,422	23.01 10,172	23.01 9,956	23.04 9,725	23.08 9,932	21.81 9,252	26.61 8,688	30.08 8,223	31.40 8,022	32.32 7,748	31.81 7,818	31.91 7,764

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Everest Organics Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
BK ADVANCE & RESEARCHLLP Promoter Group	February-2021	Market Purchase (Acquisition) 22nd Feb 2021	2.78 %	₹ 239.00	1.00 k	₹ 2.39 lac
BK ADVANCE & RESEARCHLLP Promoter Group	February-2021	Market Purchase (Acquisition) 19th Feb 2021	2.76 %	₹ 237.22	2.00 k	₹ 4.74 lac
BK ADVANCE & RESEARCHLLP Promoter Group	February-2021	Market Purchase (Acquisition) 18th Feb 2021	2.71 %	₹ 240.60	2.00 k	₹ 4.81 lac
BK ADVANCE & RESEARCHLLP Promoter Group	February-2021	Market Purchase (Acquisition) 18th Feb 2021	2.73 %	₹ 244.61	2.00 k	₹ 4.89 lac
BK ADVANCE & RESEARCHLLP Promoter Group	February-2021	Market Purchase (Acquisition) 14th Feb 2021	2.68 %	₹ 249.10	2.00 k	₹ 4.98 lac

Corporate Actions

History of Everest Organics Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.50/share
Record date: 16th Sep 2022Ex-date: 15th Sep 2022
Announced on: 27th May 2022
Dividend₹ 1/share
Record date: 10th Sep 2021Ex-date: 8th Sep 2021
Announced on: 12th Jun 2021
Dividend₹ 0.50/share
Record date: 18th Feb 2021Ex-date: 17th Feb 2021
Announced on: 8th Feb 2021
Dividend₹ 1/share
Record date: 2nd Sep 2020Ex-date: 1st Sep 2020
Announced on: 25th Jun 2020
Dividend₹ 1/share
Record date: 4th Sep 2019Ex-date: 3rd Sep 2019
Announced on: 21st May 2019

Company Profile

Overview of Everest Organics Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Everest Organics Limited is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and intermediaries. It is involved in the manufacturing of bulk drugs. The Company’s API products include Omeprazole, Pantoprazole Sodium Sesquihydrate, Esomeprazole Magnesium Trihydrate, ...

Key personnel

Mr. P. Ramakrishna

Chief Financial Officer

Mr. Narra Venkata RamanaD

Non-Executive Independent Chairman of the Board

Dr. Sirisha Sri KakarlapudiD

Chief Executive Officer, Managing Director, Executive Director

Mr. M. Bangara RajuD

Executive Independent Director, Director - Human Resources, Legal & Corporate Affairs

Mr. Srikakarlapudi HarikrishnaD

Whole-time Director

S.K.Hari KrishnaD

Executive Director

Mr. Kirankumar RampallyD

Non-Executive Independent Director

Mr. Venkata Satyanarayana Murthy VadaliD

Additional Non-Executive Independent Director

View all

Incorporated on

19 Feb 1993

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

05 Jan 1995

Free Float

22,43,041

Website

https://www.everestorganicsltd.com/

Phone no.

+914040040783

Address

AROOR VILLAGE, SADASIVAPET MANDAL,, , 502291, India

Frequently Asked Questions

What is the current share price of Everest Organics Ltd.?

The current share price of Everest Organics Ltd. is ₹ 298.05 as of 7 Aug 2026.

What is the market capitalisation of Everest Organics Ltd.?

The market capitalisation of Everest Organics Ltd. stands at ₹ 289.44 Cr.

What is the PE ratio of Everest Organics Ltd.?

The Price-to-Earnings (PE) ratio of Everest Organics Ltd. is 52.18 as of the latest trailing twelve months data.

What is the ROE and ROCE of Everest Organics Ltd.?

Everest Organics Ltd. has a Return on Equity (ROE) of 7.63% and a Return on Capital Employed (ROCE) of 10.96% as per the latest financial reports.

What is the 52-week high and low of Everest Organics Ltd.?

The 52-week high of Everest Organics Ltd. is - and the 52-week low is -.

What is the dividend yield of Everest Organics Ltd.?

The dividend yield of Everest Organics Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Everest Organics Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.02% and retail/public investors hold 31.91% of Everest Organics Ltd. shares.

What sector does Everest Organics Ltd. belong to?

Everest Organics Ltd. operates in the Healthcare sector.

What is the beta of Everest Organics Ltd.?

The beta of Everest Organics Ltd. is 0.99, indicating its price volatility relative to the broader market. Over the past 1 year, Everest Organics Ltd. has delivered an absolute return of -10.76%.

What is the RSI of Everest Organics Ltd.?

The 14-day Relative Strength Index (RSI) of Everest Organics Ltd. is 50.93, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Everest Organics Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Everest Organics Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile